Healthcare | February 04, 2022
AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
It has signed an MoU with Plan India to expand its reach to Karnataka
It has signed an MoU with Plan India to expand its reach to Karnataka
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
It has a total of 50 ANDA approvals from USFDA
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
Subscribe To Our Newsletter & Stay Updated
